Announcements

MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.

The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.

About Professor Michele Parrinello

"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”

——Professor Michele Parrinello

Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies.

For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.

Award Committee

The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process. The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award.

"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."

——Professor Xin-Gao Gong

The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.

About the MDPI Sustainability Foundation and MDPI Awards

The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields. 

In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.

Find more information on awards here.

We are honored to recognize the 2024 MDPI Top 1000 Reviewers—scholars whose exemplary commitment to rigorous and constructive peer review is vital in upholding the highest standards of academic publishing.

Selected from a distinguished pool of 215,000 reviewers from 65 countries and regions worldwide, these honorees stand out for their exceptional expertise, diligence, and dedication to advancing research through timely and thoughtful reviews. Their constructive and impartial feedback ensures the publication of high-quality, impactful research, while their timely reviews facilitate swift revisions and faster publication of innovative work.

Peer review is the invisible foundation of academic progress. With gratitude and respect, we celebrate these 1000 scholars who made that foundation stronger in 2024. We respected all privacy preferences, with part of nominees opting for limited attribution.

The names of these reviewers are listed below in alphabetical order by first name:

We are delighted to share some of the highly cited papers on rheumatology that were published in Journal of Personalized Medicine (JPM, ISSN: 2075-4426). We would also like to promote some Special Issues on this topic that are currently open for submission and may be of interest to you.

1. “The Inflammatory Profile Orchestrated by Inducible Nitric Oxide Synthase in Systemic Lupus Erythematosus”
by Corina Daniela Ene and Ilinca Nicolae
J. Pers. Med. 2023, 13(6), 934; https://doi.org/10.3390/jpm13060934
Available online: https://www.mdpi.com/2075-4426/13/6/934
Cited by 10 | Viewed by 2235+

2. “Association of Oral Health with Risk of Rheumatoid Arthritis: A Nationwide Cohort Study”
by Yoonkyung Chang, Min Kyung Chung, Jung-Hyun Park and Tae-Jin Song
J. Pers. Med. 2023, 13(2), 340; https://doi.org/10.3390/jpm13020340
Available online: https://www.mdpi.com/2075-4426/13/2/340
Cited by 9 | Viewed by 3390+

3. “Sex Bias in Diagnostic Delay: Are Axial Spondyloarthritis and Ankylosing Spondylitis Still Phantom Diseases in Women? A Systematic Review and Meta-Analysis”
by Francesca Bandinelli, Bianca Martinelli-Consumi, Mirko Manetti and Maria Sole Vallecoccia
J. Pers. Med. 2024, 14(1), 91; https://doi.org/10.3390/jpm14010091
Available online: https://www.mdpi.com/2075-4426/14/1/91
Cited by 9 | Viewed by 2765+

4. “An AI Approach to Identifying Novel Therapeutics for Rheumatoid Arthritis”
by Jency R. Rajan, Stephen McDonald, Anthony J. Bjourson, Shu-Dong Zhang and David S. Gibson
J. Pers. Med. 2023, 13(12), 1633; https://doi.org/10.3390/jpm13121633
Available online: https://www.mdpi.com/2075-4426/13/12/1633
Cited by 6 | Viewed by 3275+

5. “ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice”
by Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, Elenia Laurino, Francesca Bartoli, Arianna Damiani, Francesca Li Gobbi, Anna Panaccione, Luca Di Cato, Laura Niccoli et al.
J. Pers. Med. 2023, 13(9), 1303; https://doi.org/10.3390/jpm13091303
Available online: https://www.mdpi.com/2075-4426/13/9/1303
Cited by 6 | Viewed by 2755+

6. “The Effects of Smoking, Alcohol, and Dietary Habits on the Progression and Management of Spondyloarthritis”
by Mauro Fatica, Eneida Çela, Mario Ferraioli, Luisa Costa, Paola Conigliaro, Alberto Bergamini, Francesco Caso and Maria Sole Chimenti
J. Pers. Med. 2024, 14(12), 1114; https://doi.org/10.3390/jpm14121114
Available online: https://www.mdpi.com/2075-4426/14/12/1114
Cited by 6 | Viewed by 2640+

7. “Ultrasonographic Insights into Peripheral Psoriatic Arthritis: Updates in Diagnosis and Monitoring”
by Karina Rossi Bonfiglioli, Fernanda Oliveira de Andrade Lopes, Letícia Queiroga de Figueiredo, Luis Fernando Fernandes Ferrari and Lissiane Guedes
J. Pers. Med. 2024, 14(6), 550; https://doi.org/10.3390/jpm14060550
Available online: https://www.mdpi.com/2075-4426/14/6/550
Cited by 4 | Viewed by 5120+

8. “Drug Survival, Effectiveness and Safety of Secukinumab in Axial Spondyloarthritis up to 4 Years: A Real-Life Single Center Experience”
by Alexandra-Diana Diaconu, Cristina Pomîrleanu, Mara Russu, Georgiana Strugariu, Eugen Ancuța, Irina Ciortescu, Cristina Bologa, Bianca Codrina Morărașu, Mihai Constantin and Alexandr Ceasovschih
J. Pers. Med. 2024, 14(4), 417; https://doi.org/10.3390/jpm14040417
Available online: https://www.mdpi.com/2075-4426/14/4/417
Cited by 3 | Viewed by 2587+

Special Issues:

You can view the abovementioned articles and submit relevant papers to JPM via https://www.mdpi.com/journal/jpm.

We are delighted to share some of the highly cited papers on artificial intelligence that were published in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426). We would also like to promote some Special Issues on this topic that are currently open for submission and may be of interest to you.

1. “Advancing Patient Care: How Artificial Intelligence Is Transforming Healthcare”
by Diana Gina Poalelungi, Carmina Liana Musat, Ana Fulga, Marius Neagu, Anca Iulia Neagu, Alin Ionut Piraianu and Iuliu Fulga
J. Pers. Med. 2023, 13(8), 1214; https://doi.org/10.3390/jpm13081214
Available online: https://www.mdpi.com/2075-4426/13/8/1214
Cited by 100 | Viewed by 20,895+

2. “Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making”
by Sebastian Griewing, Niklas Gremke, Uwe Wagner, Michael Lingenfelder, Sebastian Kuhn and Jelena Boekhoff
J. Pers. Med. 2023, 13(10), 1502; https://doi.org/10.3390/jpm13101502
Available online: https://www.mdpi.com/2075-4426/13/10/1502
Cited by 53 | Viewed by 4510+

3. “Digital Twins’ Advancements and Applications in Healthcare, Towards Precision Medicine”
by Konstantinos Papachristou, Paraskevi F. Katsakiori, Panagiotis Papadimitroulas, Lidia Strigari and George C. Kagadis
J. Pers. Med. 2024, 14(11), 1101; https://doi.org/10.3390/jpm14111101
Available online: https://www.mdpi.com/2075-4426/14/11/1101
Cited by 41 | Viewed by 8605+

4. “Intelligent Digital Twins for Personalized Migraine Care”
by Parisa Gazerani
J. Pers. Med. 2023, 13(8), 1255; https://doi.org/10.3390/jpm13081255
Available online: https://www.mdpi.com/2075-4426/13/8/1255
Cited by 39 | Viewed by 5545+

5. “Breaking Barriers—The Intersection of AI and Assistive Technology in Autism Care: A Narrative Review”
by Antonio Iannone and Daniele Giansanti
J. Pers. Med. 2024, 14(1), 41; https://doi.org/10.3390/jpm14010041
Available online: https://www.mdpi.com/2075-4426/14/1/41
Cited by 36 | Viewed by 11,990+

6. “Leveraging Machine Learning for Personalized Wearable Biomedical Devices: A Review”
by Ali Olyanasab and Mohsen Annabestani
J. Pers. Med. 2024, 14(2), 203; https://doi.org/10.3390/jpm14020203
Available online: https://www.mdpi.com/2075-4426/14/2/203
Cited by 29 | Viewed by 14,055+

7. “Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking”
by Chiara Frascarelli, Giuseppina Bonizzi, Camilla Rosella Musico, Eltjona Mane, Cristina Cassi, Elena Guerini Rocco, Annarosa Farina, Aldo Scarpa, Rita Lawlor, Luca Reggiani Bonetti et al.
J. Pers. Med. 2023, 13(9), 1390; https://doi.org/10.3390/jpm13091390
Available online: https://www.mdpi.com/2075-4426/13/9/1390
Cited by 28 | Viewed by 5135+

8. “Applications of Artificial Intelligence in the Neuropsychological Assessment of Dementia: A Systematic Review”
by Isabella Veneziani, Angela Marra, Caterina Formica, Alessandro Grimaldi, Silvia Marino, Angelo Quartarone and Giuseppa Maresca
J. Pers. Med. 2024, 14(1), 113; https://doi.org/10.3390/jpm14010113
Available online: https://www.mdpi.com/2075-4426/14/1/113
Cited by 27 | Viewed by 7745+

9. “Digital Anti-Aging Healthcare: An Overview of the Applications of Digital Technologies in Diet Management”
by Tagne Poupi Theodore Armand, Hee-Cheol Kim and Jung-In Kim
J. Pers. Med. 2024, 14(3), 254; https://doi.org/10.3390/jpm14030254
Available online: https://www.mdpi.com/2075-4426/14/3/254
Cited by 23 | Viewed by 7265+

10. “AI-Driven Decision Support for Early Detection of Cardiac Events: Unveiling Patterns and Predicting Myocardial Ischemia”
by Luís B. Elvas, Miguel Nunes, Joao C. Ferreira, Miguel Sales Dias and Luís Brás Rosário
J. Pers. Med. 2023, 13(9), 1421; https://doi.org/10.3390/jpm13091421
Available online: https://www.mdpi.com/2075-4426/13/9/1421
Cited by 20 | Viewed by 4490+

Special Issues:

You can view the abovementioned articles and submit relevant papers to JPM via https://www.mdpi.com/journal/jpm.

1 December is World AIDS Day, the day is an opportunity for public and private partners to spread awareness about the status of the pandemic and encourage progress in HIV/AIDS prevention, treatment, and care around the world. It has become one of the most widely recognized international health days.

In recognition of this day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine and biology. We believe that sharing such research can raise the public’s awareness and understanding of AIDS. The aim is to strengthen scientific cooperation in response to increased awareness about HIV/AIDS and to demonstrate international solidarity in the face of the pandemic.

“Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview”
by Alex C. Boomgarden and Chitra Upadhyay
Vaccines 2025, 13(2), 148; https://doi.org/10.3390/vaccines13020148

“Drug-Drug Interactions Between HIV Antivirals and Concomitant Drugs in HIV Patients: What We Know and What We Need to Know”
by Emanuela De Bellis, Danilo Donnarumma, Adele Zarrella, Salvatore Maria Mazzeo, Annarita Pagano, Valentina Manzo, Ines Mazza, Francesco Sabbatino, Graziamaria Corbi, Pasquale Pagliano et al.
Pharmaceutics 2025, 17(1), 31; https://doi.org/10.3390/pharmaceutics17010031

“High Prevalence of High-Risk HPV Among People with and Without HIV: Insights into Risk Factors for Tailored Screening Approaches”
by Elena Bruzzesi, Federica Gandini, Sara Diotallevi, Riccardo Lolatto, Massimo Cernuschi, Caterina Candela, Angelo Roberto Raccagni, Flavia Passini, Andrea Marco Tamburini, Roberto Burioni et al.
Microorganisms 2024, 12(12), 2571; https://doi.org/10.3390/microorganisms12122571

“Association Between Left Ventricular Diastolic Dysfunction, Systemic Inflammation, and Gastrointestinal Symptoms in HIV-Positive Patients on Antiretroviral Therapy”
by Madalina-Ianca Suba, Bogdan Hogea, Ahmed Abu-Awwad, Voichita Elena Lazureanu, Ovidiu Rosca, Daniela Gurgus, Sorina Maria Denisa Laitin and Alina Abu-Awwad
Diseases 2024, 12(12), 313; https://doi.org/10.3390/diseases12120313

“NSC95397 Is a Novel HIV-1 Latency-Reversing Agent”
by Randilea Nichols Doyle, Vivian Yang, Yetunde I. Kayode, Robert Damoiseaux, Harry E. Taylor and Oliver I. Fregoso
Viruses 2024, 16(11), 1783; https://doi.org/10.3390/v16111783

“HIV Self-Testing: A Discussion on the Benefits, Limitations, and Implications for Public Health with a Focus on Poland”
by Aleksandra Kozieł, Igor Domański, Aleksandra Szymczak, Tomasz Dudzik, Brygida Knysz and Bartosz Szetela
Diagnostics 2024, 14(22), 2475; https://doi.org/10.3390/diagnostics14222475

“Tumor Initiation and Progression in People Living on Antiretroviral Therapies”
by Seun E. Olufemi, Daniel A. Adediran, Temitope Sobodu, Isaac O. Adejumo, Olumide F. Ajani and Elijah K. Oladipo
Biologics 2024, 4(4), 390-406; https://doi.org/10.3390/biologics4040024

“J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of Pseudomonas Exotoxin A”
by Seth H. Pincus, Kun Luo, Tami Peters, James T. Gordy, Frances M. Cole, Grant Klug, Kelli Ober, Tamera K. Marcotte and Richard B. Markham
Pharmaceuticals 2025, 18(9), 1305; https://doi.org/10.3390/ph18091305

“A Memo on Factors Associated with Perception of Stigma Attached to PrEP: Evidence from the Keeping It LITE Study”
by Shahin Davoudpour, Gregory L. Phillips II, Pedro A. Serrano, Audrey L. French and Sybil G. Hosek
Sexes 2024, 5(3), 300-316; https://doi.org/10.3390/sexes5030023

“Effects of E-Cigarettes on the Lung and Systemic Metabolome in People with HIV”
by Aline Zaparte, Courtney J. Christopher, Connie Arnold, Lauren Richey, Adairre Castille, Kyle Mistretta, Christopher M. Taylor, Huiyi Lin, Steve Nelson, John P. Kirwan, John W. Apolzan, Shawn R. Campagna and David A. Welsh
Metabolites 2024, 14(8), 434; https://doi.org/10.3390/metabo14080434

“Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility”
by Jelena Jadzic, Gordana Dragovic, Relja Lukic, Bozana Obradovic and Marija Djuric
J. Pers. Med. 2024, 14(8), 791; https://doi.org/10.3390/jpm14080791

“Advanced Therapies for Human Immunodeficiency Virus”
by Daniel Josef Lindegger
Med. Sci. 2024, 12(3), 33; https://doi.org/10.3390/medsci12030033

“Antiretroviral Therapy Switch in HIV-Infected Adults from a Regional HIV/AIDS Center in NE Romania”
by Isabela Ioana Loghin, Șerban Alin Rusu, Andrei Vâţă, Mihaela Cobaschi, Ion Cecan, Carmen Manciuc and Carmen Mihaela Dorobăţ
Medicina 2024, 60(6), 854; https://doi.org/10.3390/medicina60060854

“Alterations in the Gut Microbiome Composition of People Living with HIV in the Asia–Pacific Region: A Systematic Review”
by Paul Benedic U. Salvador, Patrick Josemaria d. R. Altavas, Mark Angelo S. del Rosario, Eric David B. Ornos and Leslie Michelle M. Dalmacio
Clin. Pract. 2024, 14(3), 846-861; https://doi.org/10.3390/clinpract14030066

“Systematic Review: HIV, Aging, and Housing—A North American Perspective, 2012–2023”
by Arthur S. Chaminuka, Gayle Prybutok, Victor R. Prybutok and William D. Senn
Healthcare 2024, 12(10), 992; https://doi.org/10.3390/healthcare12100992

“The Role of MicroRNAs in HIV Infection”
by Nicolas Morando, Mara Cecilia Rosenzvit, Maria A. Pando and Jens Allmer
Genes 2024, 15(5), 574; https://doi.org/10.3390/genes15050574

“HIV-TB Co-Infection and Pediatric Pathogen Dynamics” Guest Editor: Dr. Boris Kevin Tchounga Submission deadline: 15 March 2026	“HIV Expression in Diverse Cell Types: Mechanisms, Regulation, and Pathogenesis” Guest Editor: Dr. Rosemary Kiernan Submission deadline: 20 March 2026
“Research on HIV/AIDS Vaccine” Guest Editors: Dr. Portia Chipo Mutevedzi and Dr. Nagesh Kolishetti Submission deadline: 31 May 2026	“Gene and Cell Therapy: New Findings from Medical Research and Treatment” Guest Editors: Dr. Lorella Tripodi and Dr. Antonio Di Stasi Submission deadline: 30 June 2026
“Emerging Knowledge on Human Immunodeficiency Virus” Guest Editors: Dr. Giota Lourida and Prof. Dr. Dimitrios Paraskevis Submission deadline: 22 July 2026	“Nutrition Intervention in HIV Patients” Guest Editors: Dr. Meena Mahadevan Submission deadline: 10 August 2026

In support of World Antimicrobial Resistance (AMR) Awareness Week 2025, MDPI is delighted to invite you to our special webinar, “MDPI World AMR Awareness Week Webinar 2025”. This year’s theme, “Act Now: Protect Our Present, Secure Our Future”, serves as a powerful call to immediate action against one of the most pressing global health threats—antimicrobial resistance.

Through this webinar, we aim to highlight the latest research, innovations, and cross-sector collaborations addressing AMR. We hope these discussions will inspire collective action to promote the prudent use of antimicrobials, strengthen prevention and surveillance systems, and accelerate global efforts to safeguard human, animal, and environmental health.

Thank you for joining us as we raise awareness, exchange insights, and reaffirm our shared commitment to a healthier, more resilient future.

keywords: antimicrobial resistance; antifungal resistance; food chain contamination; biofilm infections; nanomedicine; microbial genetics; mycology; public health

Date: 21 November 2025
Time: 9:00 a.m. CET | 4:00 p.m. CST (Asia)
Webinar ID: 883 6849 1341
Webinar Secretariat: journal.webinar@mdpi.com

Register now for free!

Program:

After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.

Webinar Speakers:

• Dr. José Cobo-Díaz, Department of Food Hygiene and Technology, University of Leon, Spain;
• Dr. Ana Alastruey-Izquierdo, National Microbiology Center, Carlos III Health Institute, Spain;
• Dr.  Anam Ahsan, Clinical & Health Sciences / Centre for Pharmaceutical Innovation, University of South Australia, Australia;
• Prof. Dr. Michaela Lackner, Medical University of Innsbruck (MUI), Institute of Hygiene and Medical Microbiology (HMM), Austria;
• Dr.  Elena Perrin, Department of Biology, University of Florence, Italy.

World AMR Awareness Day 2025 draws attention to the urgent global challenge of antimicrobial resistance (AMR)—one of the greatest threats to public health, food security, and sustainable development. This year’s theme, “Act Now: Protect Our Present, Secure Our Future”, calls on the international community to take immediate, coordinated, and sustained action to preserve the effectiveness of life-saving antimicrobials. AMR affects every region of the world and every aspect of modern medicine, from surgery and cancer therapy to animal health and agriculture. Without effective antibiotics, common infections and minor injuries could once again become deadly.

To address this growing crisis, selected MDPI journals provide leading platforms for advancing research on antimicrobial resistance, surveillance, stewardship, and innovative therapeutic strategies. These include studies on new antibiotics, resistance mechanisms, diagnostic tools, infection control, and global policy frameworks. Through curated articles, Special Issues, and reprints, these journals foster cross-disciplinary collaboration among researchers, clinicians, and policymakers to combat AMR through innovation, education, and evidence-based practice.

World AMR Awareness Day serves as a powerful reminder that tackling antimicrobial resistance requires shared responsibility, sustained investment in research and innovation, and collective global action to secure a healthier, more resilient future for all.

“Antibacterial, Antifungal, Antiviral Activity, and Mechanisms of Action of Plant Polyphenols”
by Slavena Davidova, Angel S. Galabov and Galina Satchanska
Microorganisms 2024, 12(12), 2502; https://doi.org/10.3390/microorganisms12122502 

”An Overview of the Recent Advances in Antimicrobial Resistance”
by Manuela Oliveira, Wilson Antunes, Salete Mota, Áurea Madureira-Carvalho, Ricardo Jorge Dinis-Oliveira and Diana Dias da Silva
Microorganisms 2024, 12(9), 1920; https://doi.org/10.3390/microorganisms12091920

“A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafunesgin”
by Ana Espinel-Ingroff and Nathan P. Wiederhold
J. Fungi 2024, 10(5), 362; https://doi.org/10.3390/jof10050362

“ESKAPE: Navigating the Global Battlefield for Antimicrobial Resistance and Defense in Hospitals”
by Kamna Ravi and Baljit Singh
Bacteria 2024, 3(2), 76-98; https://doi.org/10.3390/bacteria3020006

Special Issues:

“A Six-Step Protocol for Monitoring Antimicrobial Resistance Trends Using WHONET and R: Real-World Application and R Code Integration”
by Fabio Ingravalle, Antonio Vinci, Marco Ciotti, Carla Fontana, Francesca Pica, Emanuele Sebastiani, Clara Donnoli, Martino Guido Rizzo, Dario Tedesco, Silvia D’Arezzo et al.
Methods Protoc. 2025, 8(5), 115; https://doi.org/10.3390/mps8050115 

“Improved Prognostic Accuracy of NEWS2 Score with Triage Data in Adults with Bacterial Sepsis: A Retrospective Cohort Study”
by Pietro Pozzessere, Roberto Lovero, Corrado Crocetta, Najada Firza, Vincenzo Brescia, Angela Pia Cazzolla, Mario Dioguardi, Francesco Testa, Marica Colella and Luigi Santacroce
Int. J. Transl. Med. 2025, 5(4), 44; https://doi.org/10.3390/ijtm5040044

“Prevalence and Antimicrobial Resistance of Typhoid Fever in Ghana: A Systematic Review and Meta-Analysis”
by Frederick Kungu, Aaron Awere-Duodu and Eric S. Donkor
Diseases 2025, 13(4), 113; https://doi.org/10.3390/diseases13040113

“Antimicrobial Resistance Patterns and Biofilm Analysis via Sonication in Intensive Care Unit Patients at a County Emergency Hospital in Romania”
by Ioana Roxana Codru, Bogdan Ioan Vintilă, Alina Simona Bereanu, Mihai Sava, Livia Mirela Popa and Victoria Birlutiu
Pharmaceuticals 2025, 18(2), 161; https://doi.org/10.3390/ph18020161 

Special Issues:

“Antimicrobial and Anti-Inflammatory Potentials of Silver Tungstate Nanoparticles, Cytotoxicity and Interference on the Activity of Antimicrobial Drugs”
by Washington de Souza Leal, Juliane Zacour Marinho, Isabela Penna Ceravolo, Lucas Leão Nascimento, Antonio Otávio de Toledo Patrocínio and Marcus Vinícius Dias-Souza
Drugs Drug Candidates 2025, 4(3), 30; https://doi.org/10.3390/ddc4030030

“Release Profile and Antibacterial Activity of Thymus sibthorpii Essential Oil-Incorporated, Optimally Stabilized Type I Collagen Hydrogels”
by Caglar Ersanli, Ioannis Skoufos, Konstantina Fotou, Athina Tzora, Yves Bayon, Despoina Mari, Eleftheria Sarafi, Konstantina Nikolaou and Dimitrios I. Zeugolis
Bioengineering 2025, 12(1), 89; https://doi.org/10.3390/bioengineering12010089

“Antimicrobial Peptides from Frogs of the Glandirana Genus”
by Frederick Harris, David A. Phoenix and Sarah R. Dennison
Biologics 2024, 4(4), 444-507; https://doi.org/10.3390/biologics4040027

“Phytochemical Composition and Antimicrobial and Antibiofilm Effect of Myrciaria cauliflora Hydroethanolic Extract against Staphylococcus aureus and Acinetobacter baumannii”
by Luciane Dias de Oliveira, Ana Luisa Monteiro Ribeiro, Sthéfani de Oliveira Dias, Geovani Moreira da Cruz, Raquel Teles de Menezes, Lara Steffany de Carvalho, Mariana Gadelho Gimenez Diamantino, Thaís Cristine Pereira, Maria Cristina Marcucci and Amjad Abu Hasna
Methods Protoc. 2024, 7(4), 60; https://doi.org/10.3390/mps7040060

“LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases”
by Surajit Bhattacharjya, Zhizhuo Zhang and Ayyalusamy Ramamoorthy
Biomolecules 2024, 14(3), 320; https://doi.org/10.3390/biom14030320

Special Issues:

“Antimicrobial Resistance Gene Patterns in Traditional Montenegrin Njeguški Cheese Revealed by qPCR”
by Vesna Milanović, Giorgia Rampanti, Andrea Cantarini, Federica Cardinali, Giuseppe Paderni, Aleksandra Martinovic, Andrea Brenciani, Lucia Aquilanti, Andrea Osimani and Cristiana Garofalo
Genes 2025, 16(9), 1089; https://doi.org/10.3390/genes16091089

“Immunotherapy Potential of Animal-Sourced Probiotic Bacteria”
by Isaac Oluseun Adejumo
Biologics 2025, 5(3), 17; https://doi.org/10.3390/biologics5030017

“Screening and Genomic Profiling of Antimicrobial Bacteria Sourced from Poultry Slaughterhouse Effluents: Bacteriocin Production and Safety Evaluation”
by Nuria Peña, Irene Lafuente, Ester Sevillano, Javier Feito, Diogo Contente, Estefanía Muñoz-Atienza, Luis M. Cintas, Pablo E. Hernández and Juan Borrero
Genes 2024, 15(12), 1564; https://doi.org/10.3390/genes15121564 

“The Impact of Antibiotics and Steroids on the Nasal Microbiome in Patients with Chronic Rhinosinusitis: A Systematic Review According to PICO Criteria”
by Antonella Loperfido, Carlo Cavaliere, Elona Begvarfaj, Andrea Ciofalo, Giovanni D’Erme, Marco De Vincentiis, Antonio Greco, Stefano Millarelli, Gianluca Bellocchi and Simonetta Masieri
J. Pers. Med. 2023, 13(11), 1583; https://doi.org/10.3390/jpm13111583

Special Issues:

Med. Sci. Forum, 2025, ECA 2025 The 4th International Electronic Conference on Antibiotics Organiser: MDPI and Antibiotics Volume Editors: Manuel Simões and Marc Maresca Highlights Fourier Transform Infrared Spectroscopy-Based Detection of Amoxicillin and Ampicillin for Advancing Antibiotic Monitoring with Optical Techniques by Vinicius Pereira Anjos et al. Third-Generation Cephalosporin-Resistant Escherichia coli Isolates Belonging to High-Risk Clones Obtained from Fresh Pork Meat in La Plata City, Argentina by Hernán D. Nievas et al. Click here to read the full list of papers.

World Cervical Cancer Elimination Day is an annual observance aimed at enhancing awareness of cervical cancer prevention and treatment, fostering a deeper recognition of the urgency to eliminate the disease, while also drawing attention to the global health burden it imposes—especially on women’s well-being. This day highlights the pivotal role that collective action plays in advancing cervical cancer screening, vaccination, and access to care, thereby reinforcing the imperative for its elimination. Under the theme “Act Now: Eliminate Cervical Cancer”, calls for bold, united action to build on existing progress and accelerate impact toward the 90-70-90 targets by 2030.

“Progress and Challenges in Canada’s Path Toward the Elimination of Cervical Cancer”
by Samara Perez
Curr. Oncol. 2024, 31(10), 5850-5861; https://doi.org/10.3390/curroncol31100435

“High-Risk HPV Screening Initiative in Kosovo—A Way to Optimize HPV Vaccination for Cervical Cancer”
by Jessica L. Bentz, Rachael E. Barney, Natalia Georgantzoglou, Suzana Manxhuka-Kerliu et al.
Diseases 2024, 12(8), 189; https://doi.org/10.3390/diseases12080189

“Cervical Cancer Genetic Profile through Circulating Tumor DNA: What Can We Learn from Blood?”
by Sevastiani Antonouli, Valentina Di Nisio, Nikoletta Daponte, Athina-Ioanna Daponte and Alexandros Daponte
Biomolecules 2024, 14(7), 825; https://doi.org/10.3390/biom14070825

“An Epidemiological Study of Cervical Cancer Trends among Women with Human Immunodeficiency Virus”
by Arlesia Mathis, Ukamaka D. Smith, Vanessa Crowther, Torhonda Lee and Sandra Suther
Healthcare 2024, 12(12), 1178; https://doi.org/10.3390/healthcare12121178

“Artificial Intelligence and Colposcopy: Automatic Identification of Cervical Squamous Cell Carcinoma Precursors”
by Miguel Mascarenhas, Inês Alencoão, Maria João Carinhas, Miguel Martins, Pedro Cardoso, Francisco Mendes, Joana Fernandes, João Ferreira, Guilherme Macedo and Rosa Zulmira Macedo
J. Clin. Med. 2024, 13(10), 3003; https://doi.org/10.3390/jcm13103003

“Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022”
by Marie Rykkelid, Helga Marie Wennberg, Elin Richardsen and Sveinung Wergeland Sørbye
Pathogens 2024, 13(5), 381; https://doi.org/10.3390/pathogens13050381

“Identification and Validation of eRNA as a Prognostic Indicator for Cervical Cancer”
by Lijing Huang, Jingkai Zhang, Zhou Songyang and Yuanyan Xiong
Biology 2024, 13(4), 227; https://doi.org/10.3390/biology13040227

“Cervical Cancer Associated with Pregnancy: Current Challenges and Future Strategies”
by Jennifer Le Guévelou, Lise Selleret, Enora Laas, Fabrice Lecuru and Manon Kissel
Cancers 2024, 16(7), 1341; https://doi.org/10.3390/cancers16071341

“Correlation of the HPV 16 Genotype Persistence in Women Undergoing LEEP for CIN3 with the Risk of CIN2+ Relapses in the First 18 Months of Follow-Up: A Multicenter Retrospective Study”
by Maria Teresa Bruno, Gaetano Valenti, Zaira Ruggeri, Giosuè Giordano Incognito, Paola Coretti, Giuseppe Dario Montana, Marco Marzio Panella and Liliana Mereu
Diagnostics 2024, 14(5), 509; https://doi.org/10.3390/diagnostics14050509

“Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma”
by Jialu Li and Juqun Xi
Genes 2024, 15(1), 121; https://doi.org/10.3390/genes15010121

“Pain in High-Dose-Rate Brachytherapy for Cervical Cancer: A Retrospective Cohort Study”
by Ángel Becerra-Bolaños, Miriam Jiménez-Gil, Mario Federico, Yurena Domínguez-Díaz, Lucía Valencia and Aurelio Rodríguez-Pérez
J. Pers. Med. 2023, 13(8), 1187; https://doi.org/10.3390/jpm13081187

	“Viral Infections, Chronic Inflammation and Carcinogenesis” Guest Editors: Dr. Angioletta Lasagna and Dr. Davide Dalu Submission deadline: 15 February 2026
	“Clinical Management of Cervical Cancer” Guest Editor: Dr. Vanessa Samouëlian Submission deadline: 31 March 2026
	“HPV Vaccine and Cervical Cancer Prevention” Guest Editor: Dr. Andreia Cristina de Melo Submission deadline: 30 April 2026
	“Recent Advances and Strategies for the Management of CIN and HPV Eradication Starategies for the Prevention of Uterine Cervical Cancer” Guest Editor: Dr. Masaru Sakamoto Submission deadline 30 April 2026

World Diabetes Day will take place on 14 November 2025, under the theme “Diabetes and well-being”. Diabetes is a major cause of blindness, kidney failure, heart attack, stroke and lower limb amputation. A healthy diet, physical activity and avoiding tobacco use can prevent or delay type 2 diabetes. In addition, diabetes can be treated and its consequences avoided or delayed with medication, regular screening and treatment for complications.

In recognition of this important day, we recommend the following related articles, Special Issues and journals spanning multidisciplinary fields, including clinical medicine, biology and material sciences. We believe th.at promoting such research contributes to enhanced public awareness of innovative ideas regarding the prevention, treatment and care of diabetes. This World Diabetes Day, 14 November, let us put well-being at the heart of diabetes care and start the change for a better life with diabetes.

“New-Onset Diabetes After Transplantation in Renal Recipients: A Pilot Comparative Study of Immediate vs. Extended-Release Tacrolimus Formulation”
by Ioana Adela Ratiu, Florin Bănică, Corina Moisa, Bianca Pașca, Daniela Gîtea, Iulia Dana Grosu, Gabriel Cristian Bako, Oliviu Voștinaru, Wael Abu Dayyih and Lorena Filip
Pharmaceuticals 2025, 18(10), 1532; https://doi.org/10.3390/ph18101532

“From Current Therapeutics to Multitarget Ligands: A Review of Diabetes Pharmacological Treatments”
by Francesc Cabré, Josep J. Centelles and Marta Cascante
Pharmaceutics 2025, 17(9), 1125; https://doi.org/10.3390/pharmaceutics17091125

“Impact of Antidiabetic Medication on Therapy Outcomes in Metastatic Urothelial Cancer Patients Receiving Enfortumab Vedotin Monotherapy”
by Laila Schneidewind, Bernhard Kiss, Friedemann Zengerling, Annemarie Uhlig, Niklas Klümper, Thomas Büttner, Julia Heinzelbecker, Thomas Elegeert, Cem Aksoy, Cindy Rönnau et al.
Biologics 2025, 5(3), 20; https://doi.org/10.3390/biologics5030020

“Gene–Diet Interactions in Diabetes Mellitus: Current Insights and the Potential of Personalized Nutrition”
by Angeliki Kapellou, Effie Salata, Dimitrios Miltiadis Vrachnos, Sevastiani Papailia and Spiros Vittas
Genes 2025, 16(5), 578; https://doi.org/10.3390/genes16050578

“Anti-Diabetic Therapies and Cancer: From Bench to Bedside”
by Dimitris Kounatidis, Natalia G. Vallianou, Irene Karampela, Eleni Rebelos, Marina Kouveletsou, Vasileios Dalopoulos, Petros Koufopoulos, Evanthia Diakoumopoulou, Nikolaos Tentolouris and Maria Dalamaga
Biomolecules 2024, 14(11), 1479; https://doi.org/10.3390/biom14111479

“Untargeted and Targeted Lipidomics Unveil Dynamic Lipid Metabolism Alterations in Type 2 Diabetes”
by Li Feng, Bingshu He, Jianzhen Xia and Zhonghua Wang
Metabolites 2024, 14(11), 610; https://doi.org/10.3390/metabo14110610

“Quality of Dietetic Patient Education Materials for Diabetes and Gastrointestinal Disorders: Where Can We Do Better?”
by Kelly Lambert, Olivia Hodgson and Claudia Goodman
Dietetics 2024, 3(3), 346-356; https://doi.org/10.3390/dietetics3030026

“Biomaterials Designed to Modulate Reactive Oxygen Species for Enhanced Bone Regeneration in Diabetic Conditions”
by Mingshan Li, Zhihe Zhao and Jianru Yi
J. Funct. Biomater. 2024, 15(8), 220; https://doi.org/10.3390/jfb15080220

“The Interrelationship between Diabetes Mellitus and Emotional Well-Being: Current Concepts and Future Prospects”
by Polyxeni Mangoulia, Charalampos Milionis, Eugenia Vlachou and Ioannis Ilias
Healthcare 2024, 12(14), 1457; https://doi.org/10.3390/healthcare12141457

“Are Hyperglycemia-Induced Changes in the Retina Associated with Diabetes-Correlated Changes in the Brain? A Review from Zebrafish and Rodent Type 2 Diabetes Models”
by Kaylee Augustine-Wofford, Victoria P. Connaughton and Elizabeth McCarthy
Biology 2024, 13(7), 477; https://doi.org/10.3390/biology13070477

“Interleukin-6 as a Director of Immunological Events and Tissue Regenerative Capacity in Hemodialyzed Diabetes Patients”
by Maria-Florina Trandafir, Octavian Savu, Daniela Pasarica, Coralia Bleotu and Mihaela Gheorghiu
Med. Sci. 2024, 12(2), 31; https://doi.org/10.3390/medsci12020031

“Euonymus alatus Extract Reduces Insulin Resistance in db/db Mice by Regulating the PI3K–AKT Pathway”
by Seoung-Uk. Lee, Pallavi Gurung, Til Bahadur Thapa Magar, Junmo Lim, Rajeev Shrestha, Yoon-Hee Kim and Yong-Wan Kim
Int. J. Transl. Med. 2024, 4(2), 286-297; https://doi.org/10.3390/ijtm4020018

“Personalized Diabetes Management with Digital Twins: A Patient-Centric Knowledge Graph Approach”
by Fatemeh Sarani Rad, Rasha Hendawi, Xinyi Yang and Juan Li
J. Pers. Med. 2024, 14(4), 359; https://doi.org/10.3390/jpm14040359

“NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay”
by Simona Cernea
Life 2024, 14(2), 272; https://doi.org/10.3390/life14020272

“Mitochondrial Dysfunction in Diabetes: Shedding Light on a Widespread Oversight”
by Franklyn Nonso Iheagwam, Amarachi Joy Joseph, Eniola Deborah Adedoyin, Olawumi Toyin Iheagwam and Samuel Akpoyowvare Ejoh
Pathophysiology 2025, 32(1), 9; https://doi.org/10.3390/pathophysiology32010009

“Is Tirzepatide the New Game Changer in Type 2 Diabetes?”
by Giuseppe Lisco, Olga Eugenia Disoteo, Vincenzo De Geronimo, Anna De Tullio, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Emilio Jirillo and Vincenzo Triggiani
Endocrines 2024, 5(1), 72-86; https://doi.org/10.3390/endocrines5010005

“Fostering Resilience and Wellness: The Synergy of Mindful Eating and the Mediterranean Lifestyle”
by Efstratios Christodoulou, Georgia-Eirini Deligiannidou, Christos Kontogiorgis, Constantinos Giaginis and Antonios E. Koutelidakis
Appl. Biosci. 2024, 3(1), 59-70; https://doi.org/10.3390/applbiosci3010004

“The Main Risk Factors in Type 2 Diabetes for Cognitive Dysfunction, Depression, and Psychosocial Problems: A Systematic Review”
by Maarja Randväli, Toomas Toomsoo and Jekaterina Šteinmiller
Diabetology 2024, 5(1), 40-59; https://doi.org/10.3390/diabetology5010004

“Chronic Kidney Disease in the Older Adult Patient with Diabetes”
by Raja Ravender, Maria-Eleni Roumelioti, Darren W. Schmidt, Mark L. Unruh and Christos Argyropoulos
J. Clin. Med. 2024, 13(2), 348; https://doi.org/10.3390/jcm13020348

Conference: Pharmacology 2025
Date: 16–18 December 2025
Location: Belfast, UK

MDPI will be attending Pharmacology 2025 as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.

The British Pharmacological Society’s annual “Pharmacology” conference brings together individuals from across academia, healthcare, industry and the regulatory sector to share and celebrate the latest research and developments in pharmacology and its related subject areas. The conference is a great opportunity for those studying and working to attend lectures from experts and emerging researchers, network and socialise, and showcase your own work.

The following open access journals will be represented:

• Future Pharmacology;
• Journal of Personalized Medicine;
• Journal of Clinical Medicine;
• Sclerosis;
• Scientia Pharmaceutica;
• Pharmacoepidemiology;
• Biomedicines;
• Psychoactives;
• Medicines;
• Journal of Pharmaceutical and BioTech Industry;
• Drugs and Drug Candidates.

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.miceconciergeme.com/pharmacology2025.